Reference140 articles.
1. Karlowsky JA, Kelly LJ, Thomsberry C, Jones ME, Evangelista AT, Critchley IA, Sahm DF (2002) Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network. Int JAntimicrob Agents 19: 21–31
2. Goossens H, De Mol P, Coignau H, Levy J, Grados O, Ghysels G, Innocent H, Butzler JP (1985) Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR810 (a new cephalosporin), RU28965 (a new macrokide), and other agents against enteropathogens. Antimicrob Agents Chemother 27: 388–392
3. Fernandez-Roblas R, Cabria F, Esteban J, Lopez JC, Gadea I, Soriano F (2000) In vitro activity of gemifloxacin (SB-265805) compared with 14 other antimicrobials against intestinal pathogens. J Antimicrob Chemother 46: 1023–1027
4. Rhomberg PR, Biedenbach DJ, Jones RN (2001) Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp. Diagn Microbio! Infect Dis 40: 45–49
5. Ackermann G, Schaumann R, Pless B, Claros MC, Goldstein EJ, Rodloff AC (2000) Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. Eur J Clin Microbiol Infect Dis 19: 228–232
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Quinolone Antibacterial Agents;Comprehensive Medicinal Chemistry II;2007